Apontis Pharma AG (ETR:APPH)
Germany
· Delayed Price · Currency is EUR 11.45
+0.30 (2.69%)
Apr 24, 2025, 5:36 PM CET
Apontis Pharma AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | 0.75 | -11.3 | 2.69 | -0.75 | -1.18 | Upgrade
|
| Depreciation & Amortization | 2.24 | 1.88 | 1.75 | 1.52 | 1.53 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.01 | 0.05 | 0.22 | 0.13 | Upgrade
|
| Other Operating Activities | -5.2 | 1.17 | 0.46 | 4.93 | 0.28 | Upgrade
|
| Change in Inventory | 0.74 | -2.17 | 2.11 | -3.32 | 1.16 | Upgrade
|
| Change in Accounts Payable | -0.24 | -0.72 | 2.37 | -0.62 | 0.59 | Upgrade
|
| Change in Other Net Operating Assets | -1.2 | -1.45 | 1.6 | 1.45 | -1.06 | Upgrade
|
| Operating Cash Flow | -2.9 | -12.6 | 11.02 | 3.43 | 1.45 | Upgrade
|
| Operating Cash Flow Growth | - | - | 220.96% | 136.62% | - | Upgrade
|
| Capital Expenditures | -0.01 | -0.01 | -0.08 | -0 | -0 | Upgrade
|
| Sale (Purchase) of Intangibles | -2.33 | -3.26 | -3.19 | -1.66 | -0.73 | Upgrade
|
| Investment in Securities | -0.06 | -0 | -0.02 | -0.12 | -0.05 | Upgrade
|
| Other Investing Activities | 0.07 | 0.33 | 0.62 | 0.01 | 0 | Upgrade
|
| Investing Cash Flow | -2.33 | -2.93 | -2.68 | -1.77 | -0.78 | Upgrade
|
| Short-Term Debt Issued | - | 6 | - | - | - | Upgrade
|
| Total Debt Issued | - | 6 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | -6 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -12.25 | - | Upgrade
|
| Total Debt Repaid | -6 | - | - | -12.25 | - | Upgrade
|
| Net Debt Issued (Repaid) | -6 | 6 | - | -12.25 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 38 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -1.84 | - | - | Upgrade
|
| Other Financing Activities | -0.13 | -0 | - | -5.63 | -0 | Upgrade
|
| Financing Cash Flow | -6.13 | 6 | -1.84 | 20.12 | -0 | Upgrade
|
| Net Cash Flow | -11.36 | -9.53 | 6.5 | 21.78 | 0.67 | Upgrade
|
| Free Cash Flow | -2.92 | -12.6 | 10.94 | 3.43 | 1.45 | Upgrade
|
| Free Cash Flow Growth | - | - | 218.95% | 136.43% | - | Upgrade
|
| Free Cash Flow Margin | -6.02% | -34.09% | 19.62% | 6.70% | 3.69% | Upgrade
|
| Free Cash Flow Per Share | -0.35 | -1.51 | 1.31 | 0.40 | 0.22 | Upgrade
|
| Cash Interest Paid | 0.13 | 0 | - | 2.11 | 0 | Upgrade
|
| Cash Income Tax Paid | 0.02 | 0.46 | 0 | -0.11 | 0.18 | Upgrade
|
| Levered Free Cash Flow | -6.6 | -6.47 | 7.02 | -0.03 | 0.83 | Upgrade
|
| Unlevered Free Cash Flow | -6.53 | -6.45 | 7.02 | 0.19 | 1.33 | Upgrade
|
| Change in Net Working Capital | 7.18 | -0.96 | -6.2 | 2.36 | -0.98 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.